数位糖尿病管理市场 - 全球产业规模、份额、趋势、机会和预测，按产品、类型、最终用途和地区、竞争细分，2019-2029F

2023年，全球数位化糖尿病管理市场估值为146亿美元，预计到2029年，预测期内复合年增长率为9.30%。平台和资料分析，以监测、追踪和管理糖尿病。糖尿病是一种慢性疾病，会影响身体处理葡萄糖（糖）的方式，导致血糖水平升高。有效的糖尿病管理包括仔细监测血糖、药物管理、生活方式调整以及与医疗保健提供者的定期沟通。数位解决方案提供了工具和见解，使个人能够在护理中发挥更积极的作用，从而彻底改变了这个管理流程。全球糖尿病盛行率稳定上升，推动了对有效、便利的糖尿病管理解决方案的需求。数位工具提供了一种加强病情管理的方法，从而带来更好的健康结果。

市场概况
预测期	2025-2029
2023 年市场规模	146亿美元
2029 年市场规模	249.5亿美元
2024-2029 年复合年增长率	9.30%
成长最快的细分市场	连续血糖监测系统
最大的市场	北美洲

穿戴式装置、感测器、行动应用程式和资料分析等技术的快速进步正在推动创新数位糖尿病管理解决方案的发展。这些技术为患者提供了更好的见解、即时监控和个人化建议。患者和医疗保健专业人员对糖尿病及其管理的认识不断提高，鼓励采用数位解决方案。人们正在寻求更全面、更方便的方法来监测和管理自己的病情。医疗保健行业正在向个人化医疗迈进，数位糖尿病管理解决方案在提供客製化护理方面发挥了重要作用。这些解决方案可以分析个人资料以提供个人化的治疗计划和建议。数位解决方案收集了大量资料，可用于深入了解糖尿病趋势、治疗效果和患者行为。这种数据驱动的方法使医疗保健提供者能够做出明智的决策并调整治疗计划。

主要市场驱动因素

技术进步

转向个人化护理

改善患者参与度

主要市场挑战

公平和可近性

互通性问题

主要市场趋势

行动应用程式和软体解决方案

细分市场洞察

产品洞察

类型洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：COVID-19 对全球数位糖尿病管理市场的影响

第 5 章：客户之声

第 6 章：全球数位糖尿病管理市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产品（智慧血糖仪、连续血糖监测系统、智慧胰岛素笔、智慧胰岛素帮浦、应用程式）
  • 按类型（穿戴式装置、手持装置）
  • 依最终用途（医院、家庭环境、诊断中心）
  • 按地区
  • 按公司划分 (2023)
• 市场地图

第 7 章：亚太地区数位糖尿病管理市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按类型
  • 按最终用途
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第 8 章：欧洲数位糖尿病管理市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按类型
  • 按最终用途
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 9 章：北美数位糖尿病管理市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按类型
  • 按最终用途
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 10 章：南美洲数位糖尿病管理市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按类型
  • 按最终用途
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 11 章：中东和非洲数位糖尿病管理市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按类型
  • 按最终用途
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 12 章：市场动态

• 司机
• 挑战

第 13 章：市场趋势与发展

• 最近的发展
• 产品发布
• 併购

第 14 章：全球数位糖尿病管理市场：SWOT 分析

第 15 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第 16 章：大环境分析

第17章：竞争格局

• Abbott Laboratories Inc.
• Medtronic plc
• F. Hoffmann-La Roche Ltd.
• Bayer AG
• Lifescan, Inc.
• Dexcom, Inc.
• Sanofi SA
• Insulet Corporation
• Ascensia Diabetes Care Holdings Ag
• B Braun Melsungen AG

第 18 章：策略建议

第19章调查会社について・免责事项

Global Digital Diabetes Management Market was valued at USD 14.60 billion in 2023 and is anticipated to grow in the forecast period with a CAGR of 9.30% through 2029. Digital diabetes management refers to using digital technologies, such as mobile apps, wearable devices, software platforms, and data analytics, to monitor, track, and manage diabetes. Diabetes is a chronic condition that affects how the body processes glucose (sugar), leading to high blood sugar levels. Effective diabetes management involves careful monitoring of blood sugar, medication management, lifestyle adjustments, and regular communication with healthcare providers. Digital solutions have revolutionized this management process by providing tools and insights that empower individuals to take a more active role in their care. The global prevalence of diabetes was steadily increasing, driving the demand for effective and convenient diabetes management solutions. Digital tools offered a way to enhance the management of the condition, leading to better health outcomes.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 14.60 Billion
Market Size 2029	USD 24.95 Billion
CAGR 2024-2029	9.30%
Fastest Growing Segment	Continuous Blood Glucose Monitoring System
Largest Market	North America

Rapid advancements in technology, including wearable devices, sensors, mobile apps, and data analytics, were driving the development of innovative digital diabetes management solutions. These technologies provided better insights, real-time monitoring, and personalized recommendations for patients. Growing awareness of diabetes and its management among both patients and healthcare professionals was encouraging the adoption of digital solutions. People were seeking more comprehensive and convenient ways to monitor and manage their condition. The healthcare industry was moving towards personalized medicine, and digital diabetes management solutions played a significant role in delivering tailored care. These solutions could analyze individual data to provide personalized treatment plans and recommendations. Digital solutions collected a wealth of data that could be used to gain insights into diabetes trends, treatment effectiveness, and patient behavior. This data-driven approach enabled healthcare providers to make informed decisions and adjustments to treatment plans.

Key Market Drivers

Technological Advancements

Continuous Glucose Monitoring (CGM) Systems use tiny sensors inserted under the skin to measure glucose levels in the interstitial fluid continuously. These sensors provide real-time data to wearable devices or smartphones, allowing individuals to monitor their glucose levels and trends throughout the day. Advanced CGM systems provide alerts for high and low glucose levels, helping users make timely adjustments to their treatment plans. Many modern insulin pumps are now integrated with CGM systems, creating closed-loop or hybrid closed-loop systems, also known as artificial pancreas systems. These systems automatically adjust insulin delivery based on real-time CGM data, helping to maintain more stable blood sugar levels. Smart insulin pens are equipped with Bluetooth technology to connect with mobile apps. Users can track their insulin doses, monitor injection history, and receive reminders for insulin administration. Some pens also allow users to log carbohydrate intake and physical activity for a more comprehensive picture of diabetes management. Mobile apps have become central to digital diabetes management. These apps enable users to log blood sugar readings, track meals and exercise, set medication reminders, and view trends over time. Some apps also offer personalized recommendations based on data analysis. Advanced data analytics and artificial intelligence (AI) are used to process the vast amount of data generated by digital diabetes management tools. AI algorithms can identify patterns, predict glucose trends, and provide personalized recommendations for insulin dosing, diet adjustments, and activity planning. Telemedicine platforms enable individuals with diabetes to consult healthcare professionals remotely. This is especially important for those in remote areas or unable to travel frequently. Healthcare providers can review glucose data and provide guidance through virtual appointments.

Wearable devices have become more sophisticated, providing not only glucose monitoring but also tracking of physical activity, heart rate, and sleep patterns. These devices offer a holistic view of health that can inform diabetes management decisions. Integration with EHR systems allows healthcare providers to access a patient's diabetes management data in real-time. This integration improves care coordination and enables more informed clinical decisions. Many digital diabetes management solutions incorporate behavioral change techniques, such as reminders, rewards, and social support features. These elements encourage individuals to adopt healthier habits and adhere to their management plans. User interfaces have become more intuitive and user-friendly, catering to a wide range of age groups and technological comfort levels. This enhances overall user experience and engagement. Interoperability standards have improved, allowing different devices and apps to share data seamlessly. This is crucial for holistic diabetes management and collaborative care. This factor will help in the development of Global Digital Diabetes Management Market.

Shift towards Personalized Care

Personalized care tailors' medical treatment and management strategies to individual patients' specific needs, preferences, and circumstances. In the context of diabetes management, this approach has been facilitated and enhanced by digital technologies. Diabetes is a complex condition with varying factors influencing blood sugar levels. Digital diabetes management tools gather data from individuals, such as glucose levels, dietary habits, physical activity, and medication use. By analyzing this data, these tools can offer personalized treatment plans that consider the individual's unique situation. Digital tools provide a wealth of data that can be analyzed to identify patterns, trends, and correlations in an individual's glucose levels. This data-driven approach enables healthcare providers to make more informed decisions and adjustments to treatment plans. Digital diabetes management aligns with the concept of precision medicine, which focuses on tailoring treatments based on a patient's genetic makeup, lifestyle, and environment. This approach can lead to more effective interventions and better outcomes. Continuous glucose monitoring (CGM) systems offer real-time insights into an individual's glucose fluctuations. This allows for immediate feedback and adjustments, helping users to make timely decisions about insulin doses, meals, and activities. Digital diabetes management solutions often offer personalized lifestyle recommendations. For instance, based on an individual's glucose trends, the system might suggest adjustments to diet, exercise routines, and medication timing. Advanced analytics and AI algorithms can predict future glucose trends based on historical data. This enables individuals to anticipate potential high or low blood sugar episodes and take preventive actions.

Digital platforms can provide behavioral nudges and reminders tailored to an individual's specific goals and challenges. This encourages consistent monitoring, medication adherence, and healthier lifestyle choices. Personalized care fosters greater patient engagement and motivation. When individuals see that their management plan is specifically designed for them, they are more likely to take an active role in their health. Personalized recommendations, reminders, and insights improve treatment adherence. Individuals are more likely to stick to their management plans when they feel that these plans are designed with their needs in mind. Traditional diabetes management often involves trial and error to find the right treatment regimen. Digital solutions can streamline this process by providing data-driven guidance, potentially reducing the time and frustration associated with finding effective management strategies. Personalized care through digital solutions takes a holistic view of an individual's health. It considers not only glucose levels but also factors like stress, sleep, and overall well-being, leading to more comprehensive and effective management. Personalized care promotes long-term engagement and sustainability in diabetes management. Customized plans that align with an individual's preferences and needs make it more likely that they will continue managing their condition effectively over time. This factor will pace up the demand of Global Digital Diabetes Management Market.

Improvement in Patient Engagement

Patient engagement refers to the active involvement of individuals in their own healthcare and decision-making process. Digital tools have proven to be effective in enhancing patient engagement, particularly in the context of diabetes management. Digital tools provide individuals with real-time data about their blood sugar levels, medication dosages, and lifestyle factors. This immediate access to information empowers patients to make informed decisions and take timely actions. Patients can actively monitor their glucose levels, track their dietary choices, record physical activity, and log medications. This sense of ownership and responsibility fosters empowerment and self-efficacy. Digital solutions analyze individual data to provide personalized insights and recommendations. These tailored suggestions help patients understand how their choices affect their condition, enabling them to make better choices. Many digital diabetes management tools offer reminders for medication administration, glucose monitoring, exercise, and meal planning. These reminders help patients stay on track and adhere to their treatment plans. Digital platforms allow patients to set health goals and track their progress over time. Achieving milestones and witnessing progress can boost motivation and engagement. Digital solutions provide educational resources, articles, and information about diabetes management. Educated patients are more likely to actively engage in their care and understand the importance of their actions.

Digital tools enable patients to share their data with healthcare providers remotely. This facilitates more productive discussions during appointments and allows providers to offer guidance and adjustments based on current data. Consistent engagement through digital tools fosters long-term commitment to diabetes management. Patients are more likely to sustain their efforts over time when they feel supported and see positive outcomes. Diabetes management can sometimes feel isolated. Digital platforms provide opportunities for patients to connect with others facing similar challenges, fostering a sense of community and support. Digital tools provide immediate feedback on how lifestyle choices affect blood sugar levels. This real-time feedback loop helps patients understand cause-and-effect relationships and make informed adjustments. User-friendly interfaces and mobile apps make it easy for patients to access their data and engage with their diabetes management plan from anywhere, at any time. Engaged patients are more likely to adhere to their prescribed treatment plans, including medication regimens, dietary recommendations, and exercise routines. This factor will accelerate the demand of Global Digital Diabetes Management Market.

Key Market Challenges

Equity and Accessibility

Not everyone has equal access to technology, including smartphones, tablets, and internet connectivity. This digital divide can prevent marginalized populations from benefiting from digital diabetes management solutions. Lower-income individuals may not have the financial means to afford smartphones, wearable devices, or data plans necessary for using digital tools effectively. Rural or remote areas may lack reliable internet connectivity or access to healthcare facilities that can support the use of digital solutions. Digital solutions that are not available in multiple languages or lack user-friendly interfaces can exclude individuals with limited language proficiency or low digital literacy. Older individuals may be less familiar with digital technologies, making it challenging for them to adopt and effectively use digital diabetes management tools. Digital solutions should consider cultural differences and sensitivities in their design and content to ensure relevance and acceptance among diverse populations. Vulnerable populations, including racial and ethnic minorities, may already experience health disparities. Inaccessibility to digital solutions can exacerbate these disparities by limiting their access to advanced care options.

Interoperability Issues

Interoperability refers to the ability of different systems, devices, and applications to communicate, share data, and work together seamlessly. In the context of digital diabetes management, interoperability challenges can hinder the effective exchange of data and collaboration between various tools and platforms. Digital diabetes management involves multiple devices and apps, such as glucose monitors, insulin pumps, mobile apps, and electronic health records. If these systems don't communicate well, data can become fragmented and scattered across different platforms, making it difficult to get a comprehensive view of the patient's health. Incompatibility between devices and platforms can restrict the sharing of vital health data. Healthcare providers may struggle to access complete and up-to-date information, leading to incomplete insights into a patient's condition. When systems are not interoperable, patients may need to manually enter data from one device or app into another. This is time-consuming, prone to errors, and can discourage patients from actively managing their diabetes. Healthcare providers need to seamlessly access and review patient data during appointments. Interoperability challenges can disrupt clinical workflows and hinder efficient patient care. When data from various sources cannot be integrated, valuable insights can be missed. Holistic analysis of data, which might reveal important trends and patterns, becomes difficult. Delayed or inaccessible data can lead to delayed treatment adjustments. In diabetes management, timely responses to changing glucose levels are crucial for avoiding complications.

Key Market Trends

Mobile Apps and Software Solutions

Mobile apps provide individuals with the ability to manage their diabetes directly from their smartphones or tablets. This convenience ensures that users have access to their health data and tools wherever they are, promoting consistent monitoring and management. Mobile apps can integrate with wearable devices and continuous glucose monitors (CGMs) to provide real-time data on blood sugar levels. Users can monitor trends and receive alerts for high or low glucose levels, enabling timely interventions. Apps allow users to log their blood sugar readings, meals, physical activity, and medication dosages. This comprehensive tracking creates a detailed record that can be used to identify patterns and make informed decisions. Many apps use data analytics and artificial intelligence to provide personalized insights and recommendations. These may include suggestions for meal planning, exercise routines, and medication adjustments. Apps can offer behavioral nudges and reminders to encourage users to adhere to their diabetes management plans. These reminders can be for medication doses, blood sugar checks, or even engaging in physical activity. Mobile apps often present data in a visually appealing format, such as graphs and charts. This helps users understand their glucose trends and how their choices impact their condition over time. Apps can offer educational content about diabetes management, helping users better understand their condition and make informed decisions about their lifestyle choices.

Segmental Insights

Product Insights

In 2023, in the Global Digital Diabetes Management Market continuous blood glucose monitoring system segment held the largest share and is predicted to continue expanding over the coming years. Because of its sophisticated features, like connectivity with smart gadgets that act as display devices. Additionally, it can be configured to notify patients in a specific way when specific glucose thresholds are met. The market has been divided into categories based on the product, including apps, continuous blood glucose monitoring systems, smart insulin pens, smart insulin pumps, and smart glucose meters.

Type Insights

In 2023, in the Global Digital Diabetes Management Market Wearable devices segment held the largest revenue share and is predicted to continue expanding over the coming years. Technology breakthroughs like the emergence of artificial intelligence, the introduction of novel technologies like closed-loop pump systems and smart insulin patches, and the expanding use of self-insulin delivery devices in diabetes treatment are largely to blame for the market's expansion. The market has been divided into handheld and wearable devices based on type.

Regional Insights

The North America region dominated the Global Digital Diabetes Management Market in 2023. because numerous digital blood glucose patient monitoring devices have recently received approval and because cutting-edge technology is readily available. For instance, the Omnipod 5 Automated Insulin Delivery System, which interfaces with the Dexcom G6 Continuous Glucose Monitoring (CGM), was declared FDA-cleared by Insulet Corporation in January 2022. With its built-in SmartBolus Calculator, the Omnipod 5 mobile app makes it easier to upload data and monitor patients remotely. In addition, the growing elderly population, and the burden of diabetes from changing lifestyles are anticipated to fuel market expansion.

Key Market Players

Abbott Laboratories Inc.

Medtronic plc

F. Hoffmann-La Roche Ltd.

Bayer AG

Lifescan, Inc.

Dexcom, Inc.

Sanofi SA

Insulet Corporation

Ascensia Diabetes Care Holdings Ag

B Braun Melsungen AG

Report Scope:

In this report, the Global Digital Diabetes Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Diabetes Management Market, By Product:

Smart glucose meter Continuous blood glucose monitoring system Smart insulin pens Smart insulin pumps Apps

Digital diabetes management apps

Weight & diet management apps

Digital Diabetes Management Market, By Type:

Wearable devices Handheld devices

Digital Diabetes Management Market, By End User:

Hospitals Home settings Diagnostic centers

Digital Diabetes Management Market, By region:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

South Korea

Australia

Japan

Europe

Germany

France

United Kingdom

Spain

Italy

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Diabetes Management Market.

Available Customizations:

Global Digital Diabetes Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Digital Diabetes Management Market

5. Voice of Customer

6. Global Digital Diabetes Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Smart Glucose Meter, Continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, Apps)
  • 6.2.2. By Type (Wearable Devices, Handheld Devices)
  • 6.2.3. By End Use (Hospitals, Home Settings, Diagnostic Centers)
  • 6.2.4. By Region
  • 6.2.5. By Company (2023)
• 6.3. Market Map

7. Asia Pacific Digital Diabetes Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Asia Pacific: Country Analysis
  • 7.3.1. China Digital Diabetes Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By End Use
  • 7.3.2. India Digital Diabetes Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By End Use
  • 7.3.3. Australia Digital Diabetes Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By End Use
  • 7.3.4. Japan Digital Diabetes Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By End Use
  • 7.3.5. South Korea Digital Diabetes Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By End Use

8. Europe Digital Diabetes Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Digital Diabetes Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By End Use
  • 8.3.2. Germany Digital Diabetes Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By End Use
  • 8.3.3. Spain Digital Diabetes Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By End Use
  • 8.3.4. Italy Digital Diabetes Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By End Use
  • 8.3.5. United Kingdom Digital Diabetes Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By End Use

9. North America Digital Diabetes Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. North America: Country Analysis
  • 9.3.1. United States Digital Diabetes Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By End Use
  • 9.3.2. Mexico Digital Diabetes Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By End Use
  • 9.3.3. Canada Digital Diabetes Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By End Use

10. South America Digital Diabetes Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Digital Diabetes Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By End Use
  • 10.3.2. Argentina Digital Diabetes Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By End Use
  • 10.3.3. Colombia Digital Diabetes Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By End Use

11. Middle East and Africa Digital Diabetes Management Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Product
  • 11.2.2. By Type
  • 11.2.3. By End Use
  • 11.2.4. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Digital Diabetes Management Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Product
      • 11.3.1.2.2. By Type
      • 11.3.1.2.3. By End Use
  • 11.3.2. Saudi Arabia Digital Diabetes Management Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Product
      • 11.3.2.2.2. By Type
      • 11.3.2.2.3. By End Use
  • 11.3.3. UAE Digital Diabetes Management Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Product
      • 11.3.3.2.2. By Type
      • 11.3.3.2.3. By End Use

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Product Launches
• 13.3. Mergers & Acquisitions

14. Global Digital Diabetes Management Market: SWOT Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Product

16. PESTLE Analysis

17. Competitive Landscape

• 17.1. Abbott Laboratories Inc.
  • 17.1.1. Business Overview
  • 17.1.2. Company Snapshot
  • 17.1.3. Products & Services
  • 17.1.4. Financials (In case of listed companies)
  • 17.1.5. Recent Developments
  • 17.1.6. SWOT Analysis
• 17.2. Medtronic plc
• 17.3. F. Hoffmann-La Roche Ltd.
• 17.4. Bayer AG
• 17.5. Lifescan, Inc.
• 17.6. Dexcom, Inc.
• 17.7. Sanofi SA
• 17.8. Insulet Corporation
• 17.9. Ascensia Diabetes Care Holdings Ag
• 17.10. B Braun Melsungen AG

18. Strategic Recommendations

19. About Us & Disclaimer